We are live on
!
Find out more
HS
HighVista Strategies Portfolio holdings
AUM
$362M
1-Year Est. Return
230.96%
This Fund
S&P 500
This Quarter
Est. Return
+7.61%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$175M
AUM Growth
+$9.44M
(+5.7%)
Cap. Flow
+$6.42M
Cap. Flow
% of AUM
3.67%
Top 10 Holdings %
Top 10 Hldgs %
36.64%
Holding
129
New
19
Increased
30
Reduced
20
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NLSN
Nielsen Holdings plc
NLSN
|
+$2.98M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$2.78M |
| 3 |
VMW
VMware, Inc
VMW
|
+$2.72M |
| 4 |
RPTX
Repare Therapeutics
RPTX
|
+$1.95M |
| 5 |
Cogent Biosciences
COGT
|
+$1.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$3.62M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
+$2.96M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$2.37M |
| 4 |
IDEAYA Biosciences
IDYA
|
+$1.8M |
| 5 |
Dyne Therapeutics
DYN
|
+$1.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.35% |
| 2 | Technology | 22.42% |
| 3 | Financials | 15.33% |
| 4 | Communication Services | 4.08% |
| 5 | Consumer Discretionary | 3.37% |
Similar funds
SIAG
MS
WI
BHBT
WTFG
RC
VIA
A6
HighVista Strategies's Q3 2022 Portfolio in Review
As of Q3 2022, HighVista Strategies held 129 positions worth $175M, up 5.7% from $166M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
HighVista Strategies deployed $6.42M of net new capital in Q3 2022, opening 19 new positions and adding to 30 existing holdings. Its largest new stake was Nielsen Holdings plc: 114,200 shares worth $3.17M.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 46% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Dyne Therapeutics, an estimated $1.6M trimmed.
- HighVista Strategies's largest Q3 2022 buy was Nielsen Holdings plc: 114,200 shares worth $3.17M.
- HighVista Strategies added most to Repare Therapeutics in Q3 2022, an estimated $1.95M increase.
- HighVista Strategies's biggest Q3 2022 reduction was Dyne Therapeutics, cutting an estimated $1.6M.
- HighVista Strategies fully exited Coherent Inc in Q3 2022, selling an estimated $3.62M.
- HighVista Strategies's ten largest holdings make up 37% of its $175M portfolio in Q3 2022.
- HighVista Strategies opened 19 new positions and closed 16 in Q3 2022.
- HighVista Strategies's portfolio value rose 5.7% quarter-over-quarter to $175M.
Based on HighVista Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.